![The targeted SMAC mimetic SW IV-134 augments platinum-based chemotherapy in pre-clinical models of ovarian cancer | BMC Cancer | Full Text The targeted SMAC mimetic SW IV-134 augments platinum-based chemotherapy in pre-clinical models of ovarian cancer | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-022-09367-w/MediaObjects/12885_2022_9367_Fig1_HTML.png)
The targeted SMAC mimetic SW IV-134 augments platinum-based chemotherapy in pre-clinical models of ovarian cancer | BMC Cancer | Full Text
Dirk Spitzer, PhD - Assistant Professor - Washington University School of Medicine, Department of Surgery | LinkedIn
![Dirk Spitzer's research works | Washington University in St. Louis, Missouri (WUSTL , Wash U) and other places Dirk Spitzer's research works | Washington University in St. Louis, Missouri (WUSTL , Wash U) and other places](https://www.researchgate.net/publication/303707779/figure/fig5/AS:381337165942787@1467929273235/sW-V-49-competes-for-the-sigma-2-receptor-and-enacts-erastin-mediated-death-by-inhibition_Q320.jpg)
Dirk Spitzer's research works | Washington University in St. Louis, Missouri (WUSTL , Wash U) and other places
Mesothelin's minimal MUC16 binding moiety converts TR3 into a potent cancer therapeutic via hierarchical binding events at t
![Identification of the PGRMC1 protein complex as the putative sigma-2 receptor binding site | Nature Communications Identification of the PGRMC1 protein complex as the putative sigma-2 receptor binding site | Nature Communications](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fncomms1386/MediaObjects/41467_2011_Article_BFncomms1386_Fig4_HTML.jpg)
Identification of the PGRMC1 protein complex as the putative sigma-2 receptor binding site | Nature Communications
Dirk Spitzer, PhD - Assistant Professor - Washington University School of Medicine, Department of Surgery | LinkedIn
Lysosomal Membrane Permeabilization is an Early Event in Sigma-2 Receptor Ligand Mediated Cell Death in Pancreatic Cancer
![PDF) Sigma-2 receptor agonist derivatives of 1-Cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine (PB28) induce cell death via mitochondrial superoxide production and caspase activation in pancreatic cancer | Carmen Abate ... PDF) Sigma-2 receptor agonist derivatives of 1-Cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine (PB28) induce cell death via mitochondrial superoxide production and caspase activation in pancreatic cancer | Carmen Abate ...](https://0.academia-photos.com/attachment_thumbnails/75365506/mini_magick20211129-30808-1blr03y.png?1638177119)
PDF) Sigma-2 receptor agonist derivatives of 1-Cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine (PB28) induce cell death via mitochondrial superoxide production and caspase activation in pancreatic cancer | Carmen Abate ...
![Preclinical Evaluation of an Engineered Single-Chain Fragment Variable-Fragment Crystallizable Targeting Human CD44 | Journal of Nuclear Medicine Preclinical Evaluation of an Engineered Single-Chain Fragment Variable-Fragment Crystallizable Targeting Human CD44 | Journal of Nuclear Medicine](https://jnm.snmjournals.org/sites/default/files/highwire/jnumed/62/1.cover-source.jpg)